Clinical experience with intravesical instillations of 5-aminolevulinic acid (5-ALA) for the photodynamic diagnosis using fluorescence cystoscopy for bladder cancer

Japanese Journal of Urology

Volumn 97, Issue 5, 2006, Pages 719-729

  Inoue, Keiji ^a   Karashima, Takashi ^a   Kamada, Masayuki ^a   Kurabayashi, Atsushi ^a   Ohtsuki, Yuji ^a   Shuin, Taro ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

5 aminolevulinic acid (5 ALA); Bladder cancer; Photodynamic diagnosis

Indexed keywords

AMINOLEVULINIC ACID; BICARBONATE;

ADULT; AGED; ARTICLE; BLADDER CANCER; BLADDER IRRITATION; BLUE LIGHT; CANCER DIAGNOSIS; CANCER RECURRENCE; CANCER SURGERY; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTOSCOPY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DRUG INSTILLATION; DYSPLASIA; ENDOSCOPY; FEMALE; FLUORESCENCE; FLUORESCENT LIGHTING; HISTOPATHOLOGY; HUMAN; MALE; PHOTODYNAMICS; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; TUMOR BIOPSY; TUMOR LOCALIZATION; WHITE LIGHT;

EID: 33746864536     PISSN: 00215287     EISSN: None     Source Type: Journal    
DOI: 10.5980/jpnjurol1989.97.719     Document Type: Article

References (23)

1. Lee R. and Droller MJ.: The natural history of bladder cancer. Implications for therapy. Urol. Clin. North Am., 27, 1-13, 2000.
2. Zaak D., Hungerhuber E., Schneede P., Stepp H., Frimberger D., Corvin S., Schmeller N., Kriegmair M., Hofstetter A. and Knuechel R.: Role of 5-aminolevulinic acid in the detection of urothelial premalignant lesions. Cancer, 95, 1234-1238, 2002.
3. Malik Z. and Lugaci H.: Destruction of erythroleukaemic cells by photoactivation of endogenous porphyrins. Br J. Cancer, 56, 589-595, 1987.
4. Baumgartner R., Fisslinger H., Jocham D., Lenz H., Ruprecht L., Stepp H. and Unsold E.: A fluorescence imaging device for endoscopie detection of early stage cancer-instrumental and experimental studies. Photochem. Photobiol., 46, 759-763, 1987.
5. Navone N.M., Polo C.F., Frisardi A.L., Andrade N. E. and Battle A.M.: Heme biosynthesis in human breast cancer-mimetic "in vitro" studies and some heme enzymic activity levels. Int. J. Biochem., 22, 1407-1411, 1990.
6. Fukuda H., Paredes S. and Batlle A.M.: Tumour-localizing properties of porphyrins. In vivo studies using free and liposome encapsulated aminolevulinic acid. Comp. Biochem. Physiol. B., 102, 433-436, 1992.
7. Kriegmair M., Stepp H., Steinbach P., Lumper W., Ehsan A., Stepp H.G., Rick K., Knuchel R., Baumgartner R. and Hofstetter A.: Fluorescence cystoscopy following intravesical instillation of 5-aminolevulinic acid: a new procedure with high sensitivity for detection of hardly visible urothelial neoplasias. Urol. Int., 55, 190-196, 1995.
8. Regula J., MacRobert A.J., Gorchein A. and Buonaccorsi G.A., Thorpe S.M., Spencer G.M., Hatfield A.R., Bown S.G.: Photosensitization and photodynamic therapy of oesophageal, duodenal, and colorectal tumours using 5 aminolaevulinic acid induced protoporphyrin IX-a pilot study. Gut., 36, 67-75, 1995.
9. Kennedy J.C. and Pottier R.H.: Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. J. Photochem. Photobiol. B., 30 (14), 275-292, 1992.
10. Stummer W., Stocker S., Wagner S., Stepp H., Fritsch C., Goetz C., Goetz A.E., Kiefmann R. and Reulen H.J.: Intraoperative detection of malignant gliomas by 5-aminolevulinic acid-induced porphyrin fluorescence. Neurosurgery, 42, 518-25; discussion 525-526, 1998.
11. Hisazumi H., Ueki O., Kumaki O., Naito K. and Misaki T.: Photodynamic therapy of superficial tumors and carcinoma in situ of the bladder. Can No Rinsho, 31, 697-703, 1985.
12. Misaki T., Hisazumi H., Hirata A., Kunimi K., Yamamoto H., Amano T., Kumaki O., Koshida K., Nishino A. and Nakazima K.: Photodynamic therapy of superficial bladder tumors. Hinyokika Kiyo, 32, 1941-1948, 1986.
13. Kriegmair M., Baumgartner R., Knuchel R., Stepp H., Hofstadter F. and Hofstetter A.: Detection of early bladder cancer by 5-aminolevulinic acid in-duced porphyrin fluorescence. J. Urol., 155, 105-109; discussion 109-10, 1996.
14. D'Hallewin M.A., Bezdetnaya L. and Guillemin F.: Fluorescence detection of bladder cancer: a review. Eur. Urol., 42, 417-425, 2002.
15. Filbeck T., Roessler W., Knuechel R., Straub M., Kiel H.J. and Wieland W.F.: 5-aminolevulinic acid-induced fluorescence endoscopy applied at secondary transurethral resection after conventional resection of primary superficial bladder tumors. Urology. 53, 77-81, 1999.
16. Grimbergen M.C., van Swol C.F., Jonges T.G., Boon T.A. and van Moorselaar R.J.: Reduced specificity of 5-ALA induced fluorescence in photodynamic diagnosis of transitional cell carcinoma after previous intravesical therapy. Eur. Urol., 44, 51-56, 2003.
17. Olivo M., Lau W., Manivasager V., Hoon T.P. and Christopher C.: Fluorescence confocal microscopy and image analysis of bladder cancer using 5-aminolevulinic acid. Int. J. Oncol., 22, 523-528, 2003.
18. st ed., p33, Endo-Press TM, Tuttlingen, Germany, 2004.
19. Webber J., Kessel D. and Fromm D.: Side effects and photosensitization of human tissues after aminolevulinic acid. J. Surg. Res., 68, 31-37, 1997.
20. Rick K., Sroka R., Stepp H., Kriegmair M., Huber R.M. and Jacob K., Baumgartner R.: Pharmacokinetics of 5-aminolevulinic acid-induced protoporphyrin IX in skin and blood. J. Photochem. Photobiol. B., 40, 313-319, 1997.
21. Popken G., Schultze-Seemann W., Seiler K.U., Birkel M. and Wetterauer U.: Intravesical administration of 5-aminolevulinic acid (5-ALA). Safety and pharmacokinetics of 5-ALA and its metabolite protoporphyrin IX. Eur. J. Clin. Pharmacol., 56, 241-246, 2000.
22. Filbeck T., Wimmershoff M.B., Pichlmeier U., Karrer S., Wieland W.F., Szeimies R.M. and Rossler W.: No generalized skin phototoxicity after intravesical application of 5-aminolevulinic acid for fluorescence diagnosis of superficial bladder cancer. Urol. Int., 64, 126-128, 2000.